You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 2, FEBRUARY 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hematemesis and Melena Complicating Treatment with Rauwolfia Alkaloids

LEO E. HOLLISTER, M.D.

AMA Arch Intern Med. 1957;99(2):218-221.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Alkaloids of Rauwolfia serpentina, especially reserpine, are being used widely in the treatment of hypertension and mental illness. In addition to their pharmacologic actions on the cardiovascular and central nervous systems, a variety of effects have been reported on the gastrointestinal system. Both gastric secretory and motor activity in dogs are augmented by reserpine.1 Increased volume and acidity of gastric secretions has also been found in man under the influence of reserpine.2,3 Hypermotility of the lower gastrointestinal tract is clinically evident in the occasional complaint of diarrhea in patients taking the drug. Emetic effects, suggesting hypermotility of the upper gastrointestinal tract, have been reported in animals and man.4 These actions on the gastrointestinal tract, produced in the main by the cholinergic-like action of the drug, suggest that duodenal ulcer might be activated. Such activation of ulcer in patients receiving reserpine has been reported.4

Hematemesis and melena . . . [Full Text PDF of this Article]


Author Affiliations

Palo Alto, Calif.

From the Medical Service, Veterans Administration Hospital.


Footnotes

Submitted for publication June 21, 1956.

Technical assistance for the studies on blood clotting was given by Vernon L. Henrich, B.S., and Saul L. Kanter, B.S.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.